Apretude

Active Ingredient(s): Cabotegravir
FDA Approved: * December 20, 2021
Pharm Company: * VIIV HLTHCARE
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Apretude Overview

Cabotegravir, sold under the brand name Vocabria, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection, as well as in an injectable combination with rilpivirine under the brand name Cabenuva.[6][8] It is an integrase inhibitor with a carbamoyl pyridone structure similar to that of dolutegravir.[9] Contents 1 Medical uses 2 Contraindications and interactions ...

Read more Apretude Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cabotegravir

Recent Apretude Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cabotegravir
  • For Suspension, Extended Release: 600mg/3ml (200mg/ml)
  • Tablet: 30mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cabotegravir or a similar ingredient: (4 results)